AbbVie, Genentech Scoop Up FDA Approval for Leukemia Drug Venclexta By Sam | April 11, 2016 The FDA has given the green light to the chronic lymphocytic leukemia treatment Venclexta, which will be marketed by AbbVie and Roche’s Genentech unit. Source: Drug Industry Daily Posted in Drug Industry Daily